HIIT
Other3x/week high intensity interval training for 12 weeks
NCT Number: NCT05000437
Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers. This research used experimental model to test structured high intensity interval training program with pre-post test in single group. Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety. Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness. Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Fakultas Kedokteran Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia
To ensure that there is no missing data, the research assistant who responsible for data completeness will perform daily checking. Any missing data will be stated and immediately completed. Research assistants will provide close supervision for each subject to ensure the delivery of all necessary reports.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3x/week high intensity interval training for 12 weeks
Time frame: 12 weeks
VO2Max in ml/kg/minute
Time frame: week 4
weight and height combined as BMI in kg/m2
Time frame: week 8
weight and height combined as BMI in kg/m2
Time frame: week 12
weight and height combined as BMI in kg/m2
Time frame: week 4
total fat mass in the body as percentage
Time frame: week 8
total fat mass in the body as percentage
Time frame: week 12
total fat mass in the body as percentage
Time frame: week 4
body fat stored within abdominal cavity as ratings
Time frame: week 8
body fat stored within abdominal cavity as ratings
Time frame: week 12
body fat stored within abdominal cavity as ratings
Time frame: week 4
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
Time frame: week 8
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
Time frame: week 12
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
Time frame: 12 weeks
total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride
Time frame: 12 weeks
SOD in U/mg
Time frame: 12 weeks
MDA in nmol/mg
Time frame: 12 weeks
TNF-alpha in microgram/ml
Time frame: 12 weeks
IL-6 nanogram/ml
Time frame: week 1, 6, 12
FGF21
Time frame: week 1, 6, 12
Irisin
Time frame: week 1 and 12
Montreal Cognitive Assessment as score
Time frame: week 1 and 12
N-Back test as percentage of correct answers
Time frame: week 1 and 12
Trail Making Test A and B as seconds
Indonesia University
Other
The Effectiveness and Safety of High Intensity Interval Training Based on Oxidative Stress and Inflammatory Markers in the Management of Overweight Male Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05144737
Body Weight, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT05803421
Body Weight, Cardiovascular Diseases
Daphne, Alabama, United States
View Trial DetailsNCT03843424
Adolescent Obesity, Body Weight
Alton, Illinois, United States
View Trial DetailsNCT04110717
Body Weight, Glucose Metabolism Disorders
Dublin, Ireland
View Trial Details